Literature DB >> 16871444

Clinical catecholamine neurochemistry: a legacy of Julius Axelrod.

David S Goldstein1, Graeme Eisenhofer, Irwin J Kopin.   

Abstract

1. Discoveries, insights, and concepts that Julius Axelrod introduced about the disposition and metabolism of catecholamines provided the scientific basis and spurred the development of clinical catecholamine neurochemistry. 2. Here, we provide examples of this aspect of Axelrod's scientific legacy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16871444     DOI： 10.1007/s10571-006-9041-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN： 0272-4340            Impact factor:   5.046


  27 in total

1.  3,4-Dihydroxyphenylglycol, a metabolite of epinephrine.

Authors:  I J KOPIN; J AXELROD
Journal:  Arch Biochem Biophys       Date:  1960-07       Impact factor: 4.013

2.  Cardiac sympathetic nerve function in congestive heart failure.

Authors:  G Eisenhofer; P Friberg; B Rundqvist; A A Quyyumi; G Lambert; D M Kaye; I J Kopin; D S Goldstein; M D Esler
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

3.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

4.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.

Authors:  J R Shannon; N L Flattem; J Jordan; G Jacob; B K Black; I Biaggioni; R D Blakely; D Robertson
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

5.  Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids.

Authors:  R J Wurtman; J Axelrod
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

6.  Cardiac sympathetic denervation in Parkinson disease.

Authors:  D S Goldstein; C Holmes; S T Li; S Bruce; L V Metman; R O Cannon
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

7.  Plasma catecholamines in patients with Addison's disease.

Authors:  S R Bornstein; M Breidert; M Ehrhart-Bornstein; B Kloos; W A Scherbaum
Journal:  Clin Endocrinol (Oxf)       Date:  1995-02       Impact factor: 3.478

8.  Determination of metanephrines in plasma by liquid chromatography with electrochemical detection.

Authors:  J W Lenders; G Eisenhofer; I Armando; H R Keiser; D S Goldstein; I J Kopin
Journal:  Clin Chem       Date:  1993-01       Impact factor: 8.327

9.  Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans.

Authors:  D S Goldstein; G Eisenhofer; B B Dunn; I Armando; J Lenders; E Grossman; C Holmes; K L Kirk; S Bacharach; R Adams
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094

10.  Scintigraphic localization of pheochromocytoma.

Authors:  J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245
View more
  8 in total

Review 1.  Genotype and vascular phenotype linked by catecholamine systems.

Authors:  David S Goldstein
Journal:  Circulation       Date:  2008-01-29       Impact factor: 29.690

2.  Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury.

Authors:  Ahsan Alam; Daniel T O'Connor; Mary C Perianayagam; Alexey Y Kolyada; Yuqing Chen; Fangwen Rao; Manjula Mahata; Sushil Mahata; Orfeas Liangos; Bertrand L Jaber
Journal:  Nephron Clin Pract       Date:  2010-01-20

3.  Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension.

Authors:  Arthur Lo; Lucy Norcliffe-Kaufmann; Ross Vickery; David Bourdet; Jitendra Kanodia
Journal:  Clin Auton Res       Date:  2021-03-29       Impact factor: 4.435

4.  Identifying autonomic nervous system dysfunction in acute cerebrovascular attack by assessments of heart rate variability and catecholamine levels.

Authors:  Eşref Akıl; Yusuf Tamam; Mehmet Ata Akıl; İbrahim Kaplan; Mehmet Zihni Bilik; Abdullah Acar; Banu Tamam
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun

5.  The longevity gene mIndy (I'm Not Dead, Yet) affects blood pressure through sympathoadrenal mechanisms.

Authors:  Diana M Willmes; Martin Daniels; Anica Kurzbach; Stefanie Lieske; Nicole Bechmann; Tina Schumann; Christine Henke; Nermeen N El-Agroudy; Andrey C Da Costa Goncalves; Mirko Peitzsch; Anja Hofmann; Waldemar Kanczkowski; Kristin Kräker; Dominik N Müller; Henning Morawietz; Andreas Deussen; Michael Wagner; Ali El-Armouche; Stephen L Helfand; Stephan R Bornstein; Rafael de Cabo; Michel Bernier; Graeme Eisenhofer; Jens Tank; Jens Jordan; Andreas L Birkenfeld
Journal:  JCI Insight       Date:  2021-01-25

6.  GPR88 reveals a discrete function of primary cilia as selective insulators of GPCR cross-talk.

Authors:  Aaron Marley; Regina Wai-Yan Choy; Mark von Zastrow
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

7.  Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Agata Rozycka; Margarita Lianeri; Wojciech Kozubski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

8.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.